Pathfinder Cell Therapy Stock Analysis
| PFND Stock | USD 0.0001 0.00 0.00% |
Pathfinder Cell's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Pathfinder Cell's financial risk is the risk to Pathfinder Cell stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Pathfinder Cell's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Pathfinder Cell is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Pathfinder Cell to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Pathfinder Cell is said to be less leveraged. If creditors hold a majority of Pathfinder Cell's assets, the Company is said to be highly leveraged.
Pathfinder Cell Therapy is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Pathfinder Cell pink sheet analysis is to determine its intrinsic value, which is an estimate of what Pathfinder Cell Therapy is worth, separate from its market price. There are two main types of Pathfinder Cell's stock analysis: fundamental analysis and technical analysis.
The Pathfinder Cell pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pathfinder Cell's ongoing operational relationships across important fundamental and technical indicators.
Pathfinder |
Pathfinder Pink Sheet Analysis Notes
The company had not issued any dividends in recent years. Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. PATHFINDER CELL operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 1 people.The quote for Pathfinder Cell Therapy is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Pathfinder Cell Therapy contact Richard Franklin at 617-245-0289 or learn more at https://www.pathfindercelltherapy.com.Pathfinder Cell Therapy Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Pathfinder Cell's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Pathfinder Cell Therapy or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Pathfinder Cell generated a negative expected return over the last 90 days | |
| Pathfinder Cell has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (1.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pathfinder Cell Therapy currently holds about 4 K in cash with (963 K) of positive cash flow from operations. |
Pathfinder Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pathfinder Cell's market, we take the total number of its shares issued and multiply it by Pathfinder Cell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pathfinder Cell, as well as the relationship between them.Pathfinder Cell Therapy Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pathfinder Cell middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pathfinder Cell Therapy. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Pathfinder Cell Outstanding Bonds
Pathfinder Cell issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pathfinder Cell Therapy uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pathfinder bonds can be classified according to their maturity, which is the date when Pathfinder Cell Therapy has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Pathfinder Cell Therapy Debt to Cash Allocation
Many companies such as Pathfinder Cell, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Pathfinder Cell Therapy currently holds 5.41 M in liabilities. Debt can assist Pathfinder Cell until it has trouble settling it off, either with new capital or with free cash flow. So, Pathfinder Cell's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pathfinder Cell Therapy sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pathfinder to invest in growth at high rates of return. When we think about Pathfinder Cell's use of debt, we should always consider it together with cash and equity.Pathfinder Cell Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Pathfinder Cell's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Pathfinder Cell, which in turn will lower the firm's financial flexibility.Pathfinder Cell Corporate Bonds Issued
Most Pathfinder bonds can be classified according to their maturity, which is the date when Pathfinder Cell Therapy has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Pathfinder Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Pathfinder Cell prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pathfinder shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Pathfinder Cell. By using and applying Pathfinder Pink Sheet analysis, traders can create a robust methodology for identifying Pathfinder entry and exit points for their positions.
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. PATHFINDER CELL operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 1 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Pathfinder Cell to your portfolios without increasing risk or reducing expected return.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Complementary Tools for Pathfinder Pink Sheet analysis
When running Pathfinder Cell's price analysis, check to measure Pathfinder Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pathfinder Cell is operating at the current time. Most of Pathfinder Cell's value examination focuses on studying past and present price action to predict the probability of Pathfinder Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pathfinder Cell's price. Additionally, you may evaluate how the addition of Pathfinder Cell to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |